CAMBRIDGE, MA / ACCESS Newswire / November 3, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has been dosed in a Phase 1/2 study of mRNA-2808, the Company’s investigational ...

The study, published in the journal Nature, showed the jabs provided an immunity boost that helped extend survival for ...

The study, published in the journal Nature, showed the jabs provided an immunity boost that helped extend survival for certain skin and lung cancers.

The study builds on Dr Elias Sayour’s (University of Florida) earlier research and marks a key step toward a universal cancer vaccine that boosts immunotherapy’s effectiveness.

A study published in "Nature" shows the mRNA vaccine could extend the lives of people undergoing cancer treatment.

Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

A new study suggests mRNA coronavirus vaccines effectively prolonged the lives of certain cancer patients. The study, ...

Getting a COVID shot might do more than protect against the virus – it could also help cancer patients live longer. A new ...

The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.

COVID-19 mRNA vaccines may do more than just protect against the coronavirus - they may also help the body fight cancer. In ...

Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting ...